Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Subcutaneous injection of immune proteins is well tolerated and safe, and is clinically suitable for all patients. Subcutaneous immunoglobulin is superior to intravenous immunoglobulin because it does not require intravenous access and reduces the need for prodrug therapy with glucocorticoids and antihistamines. Due to the reduction of global market participants and the time interval between plasma collection and product launch, the production of subcutaneous immunoglobulin becomes cumbersome and time-consuming, and if not managed properly, it will hinder the subcutaneous immunoglobulin market during the forecast period.
In July 2019, Shire (Baxalta) announced that Xembify has been approved by the US Food and Drug Administration. This is a new 20% subcutaneous immunoglobulin product for the treatment of patients with idiopathic immunodeficiency 2 years and older.
The increase in the incidence of autoimmune diseases will help drive the growth of this market during the forecast period. The deepening of the aging population has led to an increase in the infectivity of the elderly population, and the prevalence of several diseases such as cancer, diabetes and neurological diseases is rising, which has driven the global demand for subcutaneous immunoglobulin market.
Subcutaneous Immunoglobulins market report explains the definition, types, applications, major countries, and major players of the Subcutaneous Immunoglobulins market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Grifols
Shire (Baxalta)
CSL
By Type:
10% Purity
20% Purity
By End-User:
Primary Immunodeficiency
Secondary Immunodeficiency
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Subcutaneous Immunoglobulins Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Subcutaneous Immunoglobulins Outlook to 2028- Original Forecasts
-
2.2 Subcutaneous Immunoglobulins Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Subcutaneous Immunoglobulins Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Subcutaneous Immunoglobulins Market- Recent Developments
-
6.1 Subcutaneous Immunoglobulins Market News and Developments
-
6.2 Subcutaneous Immunoglobulins Market Deals Landscape
7 Subcutaneous Immunoglobulins Raw Materials and Cost Structure Analysis
-
7.1 Subcutaneous Immunoglobulins Key Raw Materials
-
7.2 Subcutaneous Immunoglobulins Price Trend of Key Raw Materials
-
7.3 Subcutaneous Immunoglobulins Key Suppliers of Raw Materials
-
7.4 Subcutaneous Immunoglobulins Market Concentration Rate of Raw Materials
-
7.5 Subcutaneous Immunoglobulins Cost Structure Analysis
-
7.5.1 Subcutaneous Immunoglobulins Raw Materials Analysis
-
7.5.2 Subcutaneous Immunoglobulins Labor Cost Analysis
-
7.5.3 Subcutaneous Immunoglobulins Manufacturing Expenses Analysis
8 Global Subcutaneous Immunoglobulins Import and Export Analysis (Top 10 Countries)
-
8.1 Global Subcutaneous Immunoglobulins Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Subcutaneous Immunoglobulins Export by Region (Top 10 Countries) (2017-2028)
9 Global Subcutaneous Immunoglobulins Market Outlook by Types and Applications to 2022
-
9.1 Global Subcutaneous Immunoglobulins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 10% Purity Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 20% Purity Consumption and Growth Rate (2017-2022)
-
9.2 Global Subcutaneous Immunoglobulins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Primary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Secondary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Subcutaneous Immunoglobulins Market Analysis and Outlook till 2022
-
10.1 Global Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.2.2 Canada Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.2.3 Mexico Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.2 UK Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.3 Spain Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.4 Belgium Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.5 France Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.6 Italy Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.7 Denmark Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.8 Finland Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.9 Norway Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.10 Sweden Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.11 Poland Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.12 Russia Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.3.13 Turkey Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.2 Japan Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.3 India Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.4 South Korea Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.5 Pakistan Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.6 Bangladesh Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.7 Indonesia Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.8 Thailand Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.9 Singapore Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.10 Malaysia Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.11 Philippines Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.4.12 Vietnam Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.5.2 Colombia Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.5.3 Chile Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.5.4 Argentina Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.5.5 Venezuela Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.5.6 Peru Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.5.7 Puerto Rico Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.5.8 Ecuador Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.6.2 Kuwait Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.6.3 Oman Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.6.4 Qatar Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.6.5 Saudi Arabia Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.6.6 United Arab Emirates Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.7.2 South Africa Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.7.3 Egypt Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.7.4 Algeria Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Subcutaneous Immunoglobulins Consumption (2017-2022)
-
10.8.2 New Zealand Subcutaneous Immunoglobulins Consumption (2017-2022)
11 Global Subcutaneous Immunoglobulins Competitive Analysis
-
11.1 Grifols
-
11.1.1 Grifols Company Details
-
11.1.2 Grifols Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Grifols Subcutaneous Immunoglobulins Main Business and Markets Served
-
11.1.4 Grifols Subcutaneous Immunoglobulins Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Shire (Baxalta)
-
11.2.1 Shire (Baxalta) Company Details
-
11.2.2 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Shire (Baxalta) Subcutaneous Immunoglobulins Main Business and Markets Served
-
11.2.4 Shire (Baxalta) Subcutaneous Immunoglobulins Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 CSL
-
11.3.1 CSL Company Details
-
11.3.2 CSL Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 CSL Subcutaneous Immunoglobulins Main Business and Markets Served
-
11.3.4 CSL Subcutaneous Immunoglobulins Product Portfolio
-
11.3.5 Recent Research and Development Strategies
12 Global Subcutaneous Immunoglobulins Market Outlook by Types and Applications to 2028
-
12.1 Global Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global 10% Purity Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 20% Purity Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Primary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Secondary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Subcutaneous Immunoglobulins Market Analysis and Outlook to 2028
-
13.1 Global Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.2.2 Canada Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.2.3 Mexico Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.2 UK Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.3 Spain Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.4 Belgium Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.5 France Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.6 Italy Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.7 Denmark Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.8 Finland Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.9 Norway Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.10 Sweden Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.11 Poland Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.12 Russia Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.3.13 Turkey Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.2 Japan Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.3 India Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.4 South Korea Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.8 Thailand Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.9 Singapore Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.11 Philippines Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.2 Colombia Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.3 Chile Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.4 Argentina Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.6 Peru Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.3 Oman Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.4 Qatar Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.7.2 South Africa Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.7.3 Egypt Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.7.4 Algeria Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Subcutaneous Immunoglobulins
-
Figure of Subcutaneous Immunoglobulins Picture
-
Table Global Subcutaneous Immunoglobulins Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global 10% Purity Consumption and Growth Rate (2017-2022)
-
Figure Global 20% Purity Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
Figure Global Secondary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Table North America Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Figure United States Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Canada Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Mexico Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table Europe Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Germany Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure UK Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Spain Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Belgium Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure France Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Italy Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Denmark Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Finland Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Norway Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Sweden Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Poland Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Russia Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Turkey Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table APAC Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Figure China Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Japan Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure India Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Thailand Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Singapore Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Philippines Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table South America Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Brazil Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Colombia Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Chile Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Argentina Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Peru Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table GCC Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Bahrain Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Oman Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Qatar Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table Africa Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Nigeria Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure South Africa Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Egypt Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Algeria Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table Oceania Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Figure Australia Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table Grifols Company Details
-
Table Grifols Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Subcutaneous Immunoglobulins Main Business and Markets Served
-
Table Grifols Subcutaneous Immunoglobulins Product Portfolio
-
Table Shire (Baxalta) Company Details
-
Table Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire (Baxalta) Subcutaneous Immunoglobulins Main Business and Markets Served
-
Table Shire (Baxalta) Subcutaneous Immunoglobulins Product Portfolio
-
Table CSL Company Details
-
Table CSL Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Subcutaneous Immunoglobulins Main Business and Markets Served
-
Table CSL Subcutaneous Immunoglobulins Product Portfolio
-
Figure Global 10% Purity Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 20% Purity Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Primary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Secondary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Table North America Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure United States Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Germany Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure China Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Brazil Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure Australia Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
